A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 μg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

By Endrikat Jan   Sandri Mirella   Gerlinger Christoph   Rübig Alexander   Schmidt Werner   Fortier Michel  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 220-228

Informa Healthcare

Access to resources Recommend Favorite

Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 g of ethinyl estradiol on the human endometrium

By Ludicke F.   Johannisson E.   Helmerhorst F.M.   Campana A.   Foidart J.-M.   Heithecker R.  

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 102-107

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women

By Blode Hartmut   Kowal Kristin   Roth Katrin   Reif Stefanie  

The European Journal of Contraception and Reproductive Health Care, Vol. 17, Iss. 4, 2012-08 ,pp. : 284-297

Informa Healthcare

Access to resources Recommend Favorite

The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone

By Zimmerman Yvette   Wouters Wout   Coelingh Bennink Herjan J. T.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 3, 2013-06 ,pp. : 206-214

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

By Zimmerman Yvette   Coelingh Bennink Herjan J. T.   Wouters Wout   Ebes Frieda   Fauser Bart C. J. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 6, 2013-12 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite